![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
CH Chichester, AR Buckpitt, A Chang and CG Plopper
Department of Anatomy and Cell Biology, School of Veterinary Medicine, University of California, Davis 95616.
Nonciliated bronchiolar epithelial (Clara) cells of mice are highly susceptible to toxicants that undergo metabolic activation, presumably because this cell type expresses high levels of cytochrome P450 monooxygenases. To establish the capability of these cells to metabolize an agent that causes Clara cell-selective toxicity in vivo, we evaluated the metabolism of naphthalene in isolated cells under two distinct conditions, i.e., in homogenized cell preparations supplemented with glutathione and glutathione S-transferases and in intact cells. In homogenized cell preparations naphthalene was metabolized to dihydrodiol (minor) and a single glutathione adduct (major) derived from the 1R,2S-epoxide. In intact cells the rate of formation of glutathione adduct was much lower and dihydrodiol predominated. Approximately 3-10% of racemic naphthalene oxide added to isolated homogenized cells was converted to glutathione adducts and dihydrodiol in 3-min incubations. At high concentrations of naphthalene oxide (0.25 and 0.5 mM), formation of the adduct derived from the 1R,2s- epoxide was favored. The intracellular glutathione concentration, measured by high performance liquid chromatography as the fluorescence of the monobromobimane-glutathione derivative, was 1.14 +/- 0.13 nmol/10(6) cells. To determine whether Clara cell injury results from cytotoxic metabolites of naphthalene, we assessed viability of intact cells in response to different concentrations of naphthalene and naphthalene metabolites. At high naphthalene concentrations (0.5 and 1.0 mM) cell viability decreased to 63% or less of control, whereas lower concentrations (0.1 or 0.05 mM) did not alter viability significantly. Naphthalene-induced decreases in cell viability were blocked by preincubation of Clara cells with the cytochrome P450 monooxygenase inhibitor piperonyl butoxide. The cytotoxicity of naphthalene metabolites varied. Incubation of cells with 0.5 mM dihydrodiol, 1-naphthol, or 1,2-naphthoquinone decreased cell viability to an extent similar to that produced by 0.5 mM naphthalene. In contrast, 0.5 mM naphthalene oxide and 1,4-naphthoquinone significantly decreased viability more than the parent compound. Preincubation of Clara cells with piperonyl butoxide did not affect the loss in cell viability associated with naphthalene oxide. We conclude that isolated Clara cells 1) are capable of metabolizing naphthalene, a Clara cell- specific cytotoxicant, to two major metabolites, 2) have a detectable intracellular glutathione pool, and 3) are more susceptible to specific naphthalene metabolites than to the parent compound naphthalene.
This article has been cited by other articles:
|
|
 |
|
  D. D. Sin, S. B.-Z. Cohen, A. Day, H. Coxson, and P. D. Pare Understanding the Biological Differences in Susceptibility to Chronic Obstructive Pulmonary Disease between Men and Women Proceedings of the ATS, December 1, 2007; 4(8): 671 - 674. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Ben-Zaken Cohen, P. D. Pare, S. F. P. Man, and D. D. Sin The Growing Burden of Chronic Obstructive Pulmonary Disease and Lung Cancer in Women: Examining Sex Differences in Cigarette Smoke Metabolism Am. J. Respir. Crit. Care Med., July 15, 2007; 176(2): 113 - 120. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. C. Day, C. G. Plopper, and M. V. Fanucchi Age-specific pulmonary cytochrome P-450 3A1 expression in postnatal and adult rats Am J Physiol Lung Cell Mol Physiol, July 1, 2006; 291(1): L75 - L83. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. M. Cho, R. L. Rose, and E. Hodgson IN VITRO METABOLISM OF NAPHTHALENE BY HUMAN LIVER MICROSOMAL CYTOCHROME P450 ENZYMES Drug Metab. Dispos., January 1, 2006; 34(1): 176 - 183. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. Phimister, K. J. Williams, L. S. Van Winkle, and C. G. Plopper Consequences of Abrupt Glutathione Depletion in Murine Clara Cells: Ultrastructural and Biochemical Investigations into the Role of Glutathione Loss in Naphthalene Cytotoxicity J. Pharmacol. Exp. Ther., August 1, 2005; 314(2): 506 - 513. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Wheelock, L. Zhang, M.-U. Tran, D. Morin, S. Penn, A. R. Buckpitt, and C. G. Plopper Isolation of rodent airway epithelial cell proteins facilitates in vivo proteomics studies of lung toxicity Am J Physiol Lung Cell Mol Physiol, February 1, 2004; 286(2): L399 - L410. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. K. Nichols, R. Mehta, K. Skordos, K. Mace, A. M. A. Pfeifer, B. A. Carr, T. Minko, S. W. Burchiel, and G. S. Yost 3-Methylindole-Induced Toxicity to Human Bronchial Epithelial Cell Lines Toxicol. Sci., February 1, 2003; 71(2): 229 - 236. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. S. Van Winkle, A. D. Gunderson, J. A. Shimizu, G. L. Baker, and C. D. Brown Gender differences in naphthalene metabolism and naphthalene-induced acute lung injury Am J Physiol Lung Cell Mol Physiol, May 1, 2002; 282(5): L1122 - L1134. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Pakenham, J. Lango, M. Buonarati, D. Morin, and A. Buckpitt Urinary Naphthalene Mercapturates as Biomarkers of Exposure and Stereoselectivity of Naphthalene Epoxidation Drug Metab. Dispos., March 1, 2002; 30(3): 247 - 253. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. G. Plopper, L. S. Van Winkle, M. V. Fanucchi, S. R. C. Malburg, S. J. Nishio, A. Chang, and A. R. Buckpitt Early Events in Naphthalene-Induced Acute Clara Cell Toxicity . II. Comparison of Glutathione Depletion and Histopathology by Airway Location Am. J. Respir. Cell Mol. Biol., March 1, 2001; 24(3): 272 - 281. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. A. West, C. H. Chichester, A. R. Buckpitt, N. K. Tyler, P. Brennan, C. Helton, and C. G. Plopper Heterogeneity of Clara Cell Glutathione . A Possible Basis for Differences in Cellular Responses to Pulmonary Cytotoxicants Am. J. Respir. Cell Mol. Biol., July 1, 2000; 23(1): 27 - 36. [Abstract] [Full Text]
|
|
|
|
|
|
J. F. Greene, J. Zheng, D. F. Grant, and B. D. Hammock Cytotoxicity of 1,2-epoxynaphthalene Is Correlated with Protein Binding and in Situ Glutathione Depletion in Cytochrome P4501A1 Expressing Sf-21 Cells Toxicol. Sci., February 1, 2000; 53(2): 352 - 360. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. L. Lanza, E. Code, C. L. Crespi, F. J. Gonzalez, and G. S. Yost Specific Dehydrogenation of 3-Methylindole and Epoxidation of Naphthalene by Recombinant Human CYP2F1 Expressed in Lymphoblastoid Cells Drug Metab. Dispos., July 1, 1999; 27(7): 798 - 803. [Abstract] [Full Text]
|
|
|
|
 |
|
 T. E. Gram Chemically Reactive Intermediates and Pulmonary Xenobiotic Toxicity Pharmacol. Rev., December 1, 1997; 49(4): 297 - 342. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
